Navigation Links
Closing the science-to-policy gap in maternal and child health in Africa
Date:6/29/2010

In the third of five papers in the PLoS Medicine series on maternal, neonatal, and child health in sub-Saharan Africa, Sara Bennett and Freddie Ssengooba this week discuss the challenges of getting science into policy in Africa. Dr Bennett, from Johns Hopkins University in Baltimore USA, and Dr Ssengooba from Makerere University in Uganda argue that that the technical basis for improving maternal, newborn, and child health (MNCH) in sub-Saharan Africa is largely known, but too often policy and practice are not well informed by science. Developing better policy networks in MNCH, mainstreaming the use of science in maternal, neonatal, and child health, and investing in innovative approaches to develop and applying such science are key, the authors say.

The authors conclude that "as we apply what we already know, we should continue to build institutional and individual capacity for the local adaptation and indigenization of global MNCH evidence to national and sub-national contexts, resources, and constraints."


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. Labopharm announces closing of US$20 million public offering of units
2. Sinovac Announces Closing of Common Share Offering
3. Mental Health Advocates and Community Providers Support Allentown State Hospital Closing
4. Disclosing sexual abuse is critical
5. Anesiva Stockholders Approved Merger With Arcion Therapeutics but Merger Remains Contingent on Other Closing Conditions
6. Country action is needed for maternal and child health in Africa
7. Full reproductive and sexual health rights essential for maternal health goals
8. ADHD linked to low maternal education, lone parents and welfare benefits
9. Regional differences in C-section rate not a result of maternal request: UBC study
10. PeriGen Knowledge Summit to Address Issues in Maternal Healthcare
11. Demonstrated in vivo the transfer of maternal thyroid hormones to the fetus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... A quote from Dr. Edward Hallowell, host of CRN International’s “Distraction” podcast ... glimpse into the mind of those people with ADHD. , Dr. Hallowell, a child ... people with ADHD as having “Ferrari engines for a brain, with bicycle brakes.” , ...
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff ... located in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, ... treatment for a brain tumor. , Jason Bauer and his family are longtime ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, a New York-based firm ... Boroughs, is launching a charity drive to raise funds that will benefit the Marine ... of marines and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser Salon Offers ... Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through December 31, ... with Delightful Deals on Botox® and Juvederm® just in time for the ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s entry ... through user experience. , BOC Global Events & Training Group is a professional ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... ALTO, Calif. , Dec. 7, 2016  Varian ... an update to its previously announced plans to separate ... be executed via a tax-free distribution to Varian stockholders ... stand-alone public company that will hold the Imaging Components ... expected to be executed by the end of January ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer ... trial in patients with unresectable malignant pleural mesothelioma ... (PFS). The data, presented at the 17 th ... Vienna , showed nintedanib plus ... placebo plus pemetrexed/cisplatin, with a significantly improved PFS ...
Breaking Medicine Technology: